2021
DOI: 10.1080/09637486.2021.1885015
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 24 publications
0
11
0
2
Order By: Relevance
“…Overall, 15 out of 48 studies used curcumin that in comparison to the control group produced a significant TG reduction in 10 records (Alqahtani, 2021; Bateni et al, 2021; Cicero et al, 2020; Jazayeri‐Tehrani et al, 2019; Murillo Ortiz et al, 2019; Na et al, 2013; Neta et al, 2021; Panahi et al, 2016; Panahi, Khalili, et al, 2014; Rahmani et al, 2016), in 7 records for TC (Alqahtani, 2021; Jamilian et al, 2020; Jazayeri‐Tehrani et al, 2019; Panahi et al, 2016, 2017; Panahi, Khalili, et al, 2014; Rahmani et al, 2016), in 8 for LDL‐C (Alqahtani, 2021; Jamilian et al, 2020; Jazayeri‐Tehrani et al, 2019; Neta et al, 2021; Panahi et al, 2016, 2017; Rahmani et al, 2016; Usharani et al, 2008), in one for VLDL‐C (Murillo Ortiz et al, 2019) and in 2 for Lp(a) (Panahi et al, 2017; Panahi, Khalili, et al, 2014) and a significant increase in HDL‐C levels in 5 studies (Alqahtani, 2021; Jazayeri‐Tehrani et al, 2019; Panahi et al, 2017; Rahmani et al, 2016; Usharani et al, 2008).…”
Section: Resultsmentioning
confidence: 99%
“…Overall, 15 out of 48 studies used curcumin that in comparison to the control group produced a significant TG reduction in 10 records (Alqahtani, 2021; Bateni et al, 2021; Cicero et al, 2020; Jazayeri‐Tehrani et al, 2019; Murillo Ortiz et al, 2019; Na et al, 2013; Neta et al, 2021; Panahi et al, 2016; Panahi, Khalili, et al, 2014; Rahmani et al, 2016), in 7 records for TC (Alqahtani, 2021; Jamilian et al, 2020; Jazayeri‐Tehrani et al, 2019; Panahi et al, 2016, 2017; Panahi, Khalili, et al, 2014; Rahmani et al, 2016), in 8 for LDL‐C (Alqahtani, 2021; Jamilian et al, 2020; Jazayeri‐Tehrani et al, 2019; Neta et al, 2021; Panahi et al, 2016, 2017; Rahmani et al, 2016; Usharani et al, 2008), in one for VLDL‐C (Murillo Ortiz et al, 2019) and in 2 for Lp(a) (Panahi et al, 2017; Panahi, Khalili, et al, 2014) and a significant increase in HDL‐C levels in 5 studies (Alqahtani, 2021; Jazayeri‐Tehrani et al, 2019; Panahi et al, 2017; Rahmani et al, 2016; Usharani et al, 2008).…”
Section: Resultsmentioning
confidence: 99%
“…Only three Zingiberaceae plants have been evaluated for their anti‐diabetes properties through RCTs. The eligible articles including 18 turmeric RCTs (Adab et al, 2019; Adibian et al, 2019; Asadi et al, 2019; Chuengsamarn et al, 2014; Hodaei et al, 2019; Jimenez‐Osorio et al, 2016; Khajehdehi et al, 2011; Maithili Karpaga Selvi et al, 2015; Mokhtari et al, 2021; Na et al, 2013; Neta et al, 2021; Panahi, Khalili, Sahebi, Namazi, Artkin, et al, 2017; Panahi, Khalili, Sahebi, Namazi, Reiner, et al, 2017; Panahi et al, 2018; Rahimi et al, 2016; Shafabakhsh et al, 2020; Sousa et al, 2021; Usharani et al, 2008), 14 ginger RCTs (Arablou et al, 2014; Azimi et al, 2014; Azimi et al, 2016; Carvalho et al, 2020; Carvalho et al, 2021; El Gayar et al, 2019; Khandouzi et al, 2015; Mahluji, Attari, et al, 2013; Mahluji, Ostadrahimi, et al, 2013; Makhdoomi Arzati et al, 2017; Mozaffari‐Khosravi et al, 2014; Shidfar et al, 2015; Talaei et al, 2018; Zare Javid et al, 2019) and 4 cardamom RCTs (Asbaghi et al, 2020; Azimi et al, 2014; Azimi et al, 2016; Shekarchizadeh‐Esfahani et al, 2020), compared Zingiberaceae plants with placebo.…”
Section: Resultsmentioning
confidence: 99%
“…A high risk of bias in blinding the outcome evaluation was observed in four studies because they were single‐blind trials (Azimi et al, 2014, 2016; El Gayar et al, 2019; Usharani et al, 2008). Nine trials had a high risk of incomplete outcome data (Adibian et al, 2019; Asadi et al, 2019; Carvalho et al, 2020; Neta et al, 2021; Panahi, Khalili, Sahebi, Namazi, Artkin, et al, 2017; Panahi, Khalili, Sahebi, Namazi, Reiner, et al, 2017; Panahi et al, 2018; Sousa et al, 2021; Zare Javid et al, 2019). One study had selective reporting bias (Talaei et al, 2018).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…E a Curcuma longa L. agiu na redução dos níveis metabólicos em pessoas com diabetes tipo 2. Apresentando uma diminuição significativa da glicemia, hemoglobina glicada e triglicerídeos, sendo assim eficaz no controle glicêmico (Neta et al, 2021).…”
Section: Discussionunclassified